抗生素耐药沙门氏菌在坎帕尼亚地区的人口中流通 (2010-2023)
Maria Francesca Peruzy1, Nicoletta Murru1,2, Maria Rosaria Carullo3
1Department of Veterinary Medicine and Animal Production, University of Naples "Federico II", Via Delpino 1, 80137 Naples, Italy.
Antibiotics (Basel, Switzerland)
|February 26, 2025
概括
沙门氏菌株的抗生素耐药性是一个越来越令人担忧的问题,几乎所有分离物体都对亚齐菌素具有耐药性,并且具有高的多药耐药性率. 这突显了改善感染控制和抗生素管理的迫切需要.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 细菌病原体的抗生素耐药性构成了全球健康的重大威胁.
- 在全球范围内,沙门氏菌感染继续导致大量的发病率和死亡率.
- 了解耐药性模式对于有效的治疗和公共卫生策略至关重要.
研究的目的:
- 以后期评估沙门氏菌株的抗生素耐药性概况.
- 分析13年 (2010-2023) 的耐力趋势.
- 为了识别常见的沙门氏菌血清病毒及其特定的抗生素耐药性模式.
主要方法:
- 从人类感染中分离出的680种沙门氏菌菌株的回顾性分析.
- 数据来源于沙门氏菌分类中心 (Ce.Ti.Sa) 计算机数据库 (SIGLA).
- 对22种抗生素的小组进行抗菌敏感性测试.
主要成果:
- 观察到高患病率的耐药性,特别是对亚齐胺素 (99.4%),硫胺,四环素,链杆菌素和安培素.
- 在45.8%的测试菌株中检测到多种药物耐药性 (MDR).
- 在研究期间观察到对西普罗夫洛克萨的耐药性增加;血清器特异性耐药性有显著的变化.
结论:
- 该研究显示,抗生素耐药沙门氏菌菌株的增加令人担忧.
- 迫切需要加强感染预防措施和在人类和兽医中明智地使用抗生素.
- 开发新型抗菌剂对于打击新出现的耐药性至关重要.
相关概念视频
Antibiotic Selection
52.2K
Overview
52.2K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Bacterial Transformation
55.0K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.0K
Genomic DNA in Prokaryotes
43.3K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.3K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


